improved

Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

March 01, 2025 12:45 ET  | Source: Celldex Therapeutics, Inc. - Greatly improved patient quality of life and reduced disease…

2 months ago
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to EpidiolexArtelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

February 14, 2025 09:00 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

3 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility SolutionTango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Networks Recognized by Frost & Sullivan for Enabling Collaboration Among Distributed Teams and improved Employee-customer Interactions with Its Global Business Mobility Solution

Tango Extend provides organizations with a cost-effective, non-disruptive, reliable, and compliant mobile communications solution that enables access to essential business…

4 months ago
New Phase IIIB data shows Novartis Fabhalta improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapyNew Phase IIIB data shows Novartis Fabhalta improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy

New Phase IIIB data shows Novartis Fabhalta improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy

In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients…

5 months ago